Silicone breast implant litigation
GPTKB entity
Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:law
|
| gptkbp:affects |
medical device
FDA policy class action procedures corporate liability law medical malpractice law public perception of implants |
| gptkbp:allegedHarm |
gptkb:cancer
autoimmune disease connective tissue disease rupture |
| gptkbp:beganIn |
1980s
|
| gptkbp:defendant |
implant manufacturers
|
| gptkbp:FDAAction |
1992 moratorium on silicone breast implants
2006 re-approval of silicone breast implants |
| https://www.w3.org/2000/01/rdf-schema#label |
Silicone breast implant litigation
|
| gptkbp:involvedIn |
gptkb:Union_Carbide
gptkb:Baxter_Healthcare gptkb:Dow_Corning gptkb:3M gptkb:Bristol-Myers_Squibb mentor Inamed |
| gptkbp:involvedPlaintiff |
women with breast implants
|
| gptkbp:mediaCoverage |
widespread in 1990s
|
| gptkbp:notableCase |
gptkb:Dow_Corning_Settlement_Program
gptkb:MDL_926 |
| gptkbp:peakPeriod |
1990s
|
| gptkbp:relatedTo |
gptkb:Dow_Corning
product liability class action lawsuit breast implant |
| gptkbp:requires |
gptkb:fraud
breach of warranty failure to warn negligence defective product |
| gptkbp:resultedIn |
gptkb:Dow_Corning_bankruptcy
gptkb:FDA_moratorium public awareness scientific studies implant recalls multibillion dollar settlements revised FDA regulations |
| gptkbp:scientificReview |
gptkb:Institute_of_Medicine_1999_report
no conclusive link to systemic disease |
| gptkbp:bfsParent |
gptkb:Dow_Chemical_Company
|
| gptkbp:bfsLayer |
5
|